News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Akorn, Inc. Reports Second Quarter 2010 Results
August 3, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ:AKRX), a niche generic pharmaceutical company, today reported financial results for the second quarter ended June 30, 2010.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Layoffs
Exelixis Lays Off 130 as Pennsylvania Site Closes Down
August 28, 2025
·
2 min read
·
Tristan Manalac
Obesity
Novo Seeks RNA Approach to Obesity, Diabetes With $550M Replicate Deal
August 28, 2025
·
1 min read
·
Tristan Manalac
Special edition
Deep Dive: Women in Biopharma
August 27, 2025
·
1 min read
·
Annalee Armstrong
Rare diseases
Amylyx Axes Drug Program for Rare Neurodegenerative Disorder
August 27, 2025
·
2 min read
·
Tristan Manalac
